Dapaglip 5 mg TabDescriptionDapagliflozin is an inhibitor of Sodium-Glucose Cotransporter 2 (SGLT2). By inhibiting SGLT2, Dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Thus reduces blood sugar level..